Disturbing news about hormone replacement for post-menopausal women: researchers at the Cancer Epidemiology Unit at the University of Oxford in England who analyzed data on 126,920 postmenopausal women found that use of any hormone therapy was associated with a 29 percent increased risk of ovarian cancer compared to women who had never used hormone therapy. Web MD reports that the study, which had nine years of followup, also found that current use of estrogen-only therapy was associated with a 63 percent increased risk of ovarian cancer. Current use of estrogen-progestin combination therapy was not associated with any increased risk, but women who had used some form of hormone therapy for five or more years had a 45 percent higher risk for ovarian cancer compared with women who had never used hormone therapy. Web MD also reports that a study published last month in The Journal of the American Medical Association found that postmenopausal women who take a combination of estrogen and progestin therapy face a greater risk for developing a more advanced form of breast cancer and an increased risk for dying from the disease.
Health, fitness and lifestyle tips for people over 50 who still like to play hard
Saturday, May 31, 2025